These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 12628850

  • 1. Expression of deoxycytidine kinase in leukaemic cells compared with solid tumour cell lines, liver metastases and normal liver.
    van der Wilt CL, Kroep JR, Loves WJ, Rots MG, Van Groeningen CJ, Kaspers GJ, Peters GJ.
    Eur J Cancer; 2003 Mar; 39(5):691-7. PubMed ID: 12628850
    [Abstract] [Full Text] [Related]

  • 2. Immunocytochemical detection of deoxycytidine kinase in haematological malignancies and solid tumours.
    Hubeek I, Peters GJ, Broekhuizen AJ, Talianidis I, Sigmond J, Gibson BE, Creutzig U, Giaccone G, Kaspers GJ.
    J Clin Pathol; 2005 Jul; 58(7):695-9. PubMed ID: 15976334
    [Abstract] [Full Text] [Related]

  • 3. Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity.
    Kroep JR, Loves WJ, van der Wilt CL, Alvarez E, Talianidis I, Boven E, Braakhuis BJ, van Groeningen CJ, Pinedo HM, Peters GJ.
    Mol Cancer Ther; 2002 Apr; 1(6):371-6. PubMed ID: 12477049
    [Abstract] [Full Text] [Related]

  • 4. Effect of dexamethasone on the antileukemic effect of cytarabine: role of deoxycytidine kinase.
    Jaramillo AC, Bergman AM, Comijn EM, Jansen G, Kaspers GJL, Cloos J, Peters GJ.
    Nucleosides Nucleotides Nucleic Acids; 2020 Apr; 39(10-12):1346. PubMed ID: 32727269
    [Abstract] [Full Text] [Related]

  • 5. Expression of deoxycytidine kinase and phosphorylation of 2-chlorodeoxyadenosine in human normal and tumour cells and tissues.
    Spasokoukotskaja T, Arnér ES, Brosjö O, Gunvén P, Juliusson G, Liliemark J, Eriksson S.
    Eur J Cancer; 1995 Apr; 31A(2):202-8. PubMed ID: 7718326
    [Abstract] [Full Text] [Related]

  • 6. Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines.
    Shord SS, Patel SR.
    J Exp Clin Cancer Res; 2009 Jun 06; 28(1):76. PubMed ID: 19500405
    [Abstract] [Full Text] [Related]

  • 7. Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine.
    Galmarini CM, Thomas X, Graham K, El Jafaari A, Cros E, Jordheim L, Mackey JR, Dumontet C.
    Br J Haematol; 2003 Jul 06; 122(1):53-60. PubMed ID: 12823345
    [Abstract] [Full Text] [Related]

  • 8. Pharmacogenetics of deoxycytidine kinase: identification and characterization of novel genetic variants.
    Lamba JK, Crews K, Pounds S, Schuetz EG, Gresham J, Gandhi V, Plunkett W, Rubnitz J, Ribeiro R.
    J Pharmacol Exp Ther; 2007 Dec 06; 323(3):935-45. PubMed ID: 17855478
    [Abstract] [Full Text] [Related]

  • 9. A novel RT-PCR-based protein activity truncation assay for direct assessment of deoxycytidine kinase in small numbers of purified leukemic cells.
    Veuger MJ, Honders MW, Landegent JE, Willemze R, Barge RM.
    Leukemia; 2000 Sep 06; 14(9):1678-84. PubMed ID: 10995016
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Stratification of nucleoside analog chemotherapy using 1-(2'-deoxy-2'-18F-fluoro-β-D-arabinofuranosyl)cytosine and 1-(2'-deoxy-2'-18F-fluoro-β-L-arabinofuranosyl)-5-methylcytosine PET.
    Lee JT, Campbell DO, Satyamurthy N, Czernin J, Radu CG.
    J Nucl Med; 2012 Feb 06; 53(2):275-80. PubMed ID: 22302964
    [Abstract] [Full Text] [Related]

  • 14. Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside.
    Flasshove M, Strumberg D, Ayscue L, Mitchell BS, Tirier C, Heit W, Seeber S, Schütte J.
    Leukemia; 1994 May 06; 8(5):780-5. PubMed ID: 7514246
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Role of deoxycytidine kinase (dCK) activity in gemcitabine's radioenhancement in mice and human cell lines in vitro.
    Grégoire V, Rosier JF, De Bast M, Bruniaux M, De Coster B, Octave-Prignot M, Scalliet P.
    Radiother Oncol; 2002 Jun 06; 63(3):329-38. PubMed ID: 12142097
    [Abstract] [Full Text] [Related]

  • 17. The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia.
    Hubeek I, Stam RW, Peters GJ, Broekhuizen R, Meijerink JP, van Wering ER, Gibson BE, Creutzig U, Zwaan CM, Cloos J, Kuik DJ, Pieters R, Kaspers GJ.
    Br J Cancer; 2005 Dec 12; 93(12):1388-94. PubMed ID: 16333246
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenografts.
    Ruiz van Haperen VW, Veerman G, Braakhuis BJ, Vermorken JB, Boven E, Leyva A, Peters GJ.
    Eur J Cancer; 1993 Dec 12; 29A(15):2132-7. PubMed ID: 8297652
    [Abstract] [Full Text] [Related]

  • 20. [Relationship between the expression of the genes encoding the key enzymes for cytarabine metabolism and the pharmacokinetics of cytarabine in the treatment of childhood acute leukemia with high-dose cytarabine].
    Xie XT, Jiang SY, Li BS, Yang LL.
    Zhonghua Er Ke Za Zhi; 2008 Apr 12; 46(4):276-80. PubMed ID: 19099730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.